AMRINDER DHANOYA: Open Payments
NPI 1255040176 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,126 in 93 payments from 17 companies in 2025. Trend: 2023 $1,159 · 2024 $2,442 · 2025 $2,126
Food & beverage: $2,126
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $434 |
| Amgen Inc. | 12 | $263 |
| GlaxoSmithKline, LLC. | 8 | $215 |
| Janssen Biotech, Inc. | 7 | $214 |
| UCB, Inc. | 7 | $181 |
| Radius Health, Inc. | 6 | $157 |
| AstraZeneca Pharmaceuticals LP | 5 | $145 |
| Aurinia Pharma U.S., Inc. | 5 | $121 |
| PFIZER INC. | 3 | $95 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
Products named: RINVOQ, BENLYSTA, TREMFYA, Tymlos, Bimzelx, SAPHNELO, LUPKYNIS, XELJANZ.
Industry payments across CA — which companies pay providers there.
